Double-Blind, Placebo-Controlled Trial of Ziprasidone (Geodon) for the Depressive Mixed State.
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2016
At a glance
- Drugs Ziprasidone (Primary)
- Indications Bipolar II disorders; Major depressive disorder
- Focus Therapeutic Use
- 22 May 2010 Results were presented at the 163rd Annual Meeting of the American Psychiatric Association.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History